Contineum Therapeutics, Inc. Class A Common Stock (CTNM) stock news · $429.6M cap
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) is a biotechnology company listed on US.
This CTNM news page leads with what Contineum Therapeutics, Inc. Class A Common Stock filed — not a scraped headline mill.
No cached 8-K sentence for CTNM yet. We will not pad this page with generic market recap.
Latest reported CTNM revenue for 2024-12-31 was $0. Net income was -$42.3M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. CTNM currently screens at market cap $429.6M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the CTNM stock page; for the tape open the quote page.
CTNM latest headlines
Newest · 2026-11-03T21:05:00.000Z
- Contineum Therapeutics Reports Third-Quarter 2026 Financial Results — Yahoo Finance
- Contineum Therapeutics to Present at the Stifel 2026 Healthcare Conference — Yahoo Finance
- All You Need to Know About Contineum Therapeutics, Inc. (CTNM) Rating Upgrade to Buy — Yahoo Finance
- Contineum Therapeutics Shares Surge 27% After Bristol Myers Squibb Reports Positive Phase 3 Trial Results — Yahoo Finance
- Contineum drops 25% on mixed Bristol Myers IPF data; Stifel keeps Buy rating — Yahoo Finance
- J&J and Contineum’s Depression Drug Missed Phase 2 Goal. What Comes Next? — Yahoo Finance
+6 older headlines in the full archive.
These headlines as JSON? API free 100/dayCTNM stock news FAQ
What is CTNM's latest news headline?
The latest cached Contineum Therapeutics, Inc. Class A Common Stock (CTNM) headline on this page is "Contineum Therapeutics Reports Third-Quarter 2026 Financial Results" from Yahoo Finance on Nov 3, 2026. Story: https://lician.com/news/ctnm/12592. News: https://lician.com/news/ctnm
When was the latest cached CTNM headline published?
The latest cached Contineum Therapeutics, Inc. Class A Common Stock (CTNM) headline on this page was published Nov 3, 2026. The earliest headline date on this page is Jun 30, 2026.
How many CTNM headlines are listed on this page?
This page lists 12 cached Contineum Therapeutics, Inc. Class A Common Stock (CTNM) headlines. News: https://lician.com/news/ctnm
What other CTNM headlines are listed on this page?
Other cached headlines on this Contineum Therapeutics, Inc. Class A Common Stock (CTNM) news page: "Contineum Therapeutics to Present at the Stifel 2026 Healthcare Conference"; "All You Need to Know About Contineum Therapeutics, Inc. (CTNM) Rating Upgrade to Buy"; "Contineum Therapeutics Shares Surge 27% After Bristol Myers Squibb Reports Positive Phase 3 Trial Results". News: https://lician.com/news/ctnm
What source is listed on the CTNM news page?
The cached source on this Contineum Therapeutics, Inc. Class A Common Stock (CTNM) news page is Yahoo Finance. News: https://lician.com/news/ctnm
What does the latest CTNM headline say?
The latest cached Contineum Therapeutics, Inc. Class A Common Stock (CTNM) headline is "Contineum Therapeutics Reports Third-Quarter 2026 Financial Results". SAN DIEGO, November 03, 2026--Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated small molecule therapies for inflammatory and fibrotic diseases with significant unmet need, today reported its third-quarter 2026 financial results.
What is CTNM's latest net income?
Latest cached Contineum Therapeutics, Inc. Class A Common Stock (CTNM) net income was -$42.3M. Statements: https://lician.com/financials/ctnm
Where is CTNM stock news listed?
Cached stock news for Contineum Therapeutics, Inc. Class A Common Stock (CTNM) is listed at https://lician.com/news/ctnm. Filings: https://lician.com/sec/ctnm
Not investment advice.